| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/15/2004 | US6750194 Administering to the subject a safe and effective amount of a vpac receptor agonist selected from the group consisting of ro 25-1553, and pacap-38 |
| 06/15/2004 | US6750058 For treatment and prevention of human and animal diseases; in particular capable of dispensing to suitable target cells nucleic sequences, proteins, peptides and chemical substances via transfection |
| 06/15/2004 | US6750034 Useful as therapeutic agents for cancer, skin disorders, neuropathic pain, inflammatory, or coagulation diathesis/thrombosis; may also be useful for laundry detergents and skin care products; derived from humans |
| 06/15/2004 | US6750012 For identifying compounds that do not induce motor side effects |
| 06/15/2004 | US6750008 Use of peptides for inhibition of human and non-human retroviral, especially hiv, transmission to uninfected cells |
| 06/15/2004 | US6749870 Compositions and methods for the control of smoking |
| 06/15/2004 | US6749858 Nucleotide sequences coding polypeptide for use in the prevention of streptoccocus infection |
| 06/15/2004 | US6749840 Contacting the melanocyte with a melanin synthesis inhibiting amount of a fatty acid synthase (fas) inhibitor (such as cerulenin) to reduce melanin synthesis in the melanocyte |
| 06/15/2004 | US6749587 Modular infusion device and method |
| 06/15/2004 | CA2088334C Fast dissolving tablet and its production |
| 06/15/2004 | CA2086642C Method of treating hyperproliferative vascular disease |
| 06/13/2004 | CA2451267A1 Pharmaceutical uses for alpha2delta ligands |
| 06/10/2004 | WO2004048974A1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 06/10/2004 | WO2004048591A2 Methods for cohort selection and longevity studies |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048431A2 Polyphosphazene immunocstimulants |
| 06/10/2004 | WO2004047866A2 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 06/10/2004 | WO2004047842A1 Treatment of immune system dysfunction |
| 06/10/2004 | WO2004047830A2 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor and the use of said composition for treating bladder dysfunction |
| 06/10/2004 | WO2004047827A1 Method for promoting nail growth using thyromimetic compounds |
| 06/10/2004 | WO2004047826A1 Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance |
| 06/10/2004 | WO2004047824A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 06/10/2004 | WO2004047821A1 Methods for preventing phototoxic damage during photodynamic therapy |
| 06/10/2004 | WO2004047766A2 Treatment for sma disease |
| 06/10/2004 | WO2004047737A2 Nucleotide based medicament and method of use for treatment of conditions in humans |
| 06/10/2004 | WO2004047732A2 Tocopherol and tocotrienol medicaments |
| 06/10/2004 | WO2004047727A2 Compositions and methods for diagnosing and treating mood disorders |
| 06/10/2004 | WO2004047673A2 Treatment of liver disease with active vitamin d compounds |
| 06/10/2004 | WO2004047566A1 Nutritional compositions |
| 06/10/2004 | WO2004037843A3 Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments |
| 06/10/2004 | WO2004035030A3 Combinations of benzodithiazoles and cox-2 inhibitors for the treatment of pain |
| 06/10/2004 | WO2004033484A3 Use of stable glutamine derivatives to improve drug absorption |
| 06/10/2004 | WO2004030743A3 Drug delivery device having coated microprojections incorporating vasoconstrictors |
| 06/10/2004 | WO2004026241A3 Multistage formulation containing a biguanide and thiazolidindione derivatives |
| 06/10/2004 | WO2004020468A3 Interferon beta-like molecules for treatment of cancer |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2004010924A3 Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof |
| 06/10/2004 | WO2004004698A3 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/10/2004 | WO2004004633A3 Use of tnfalpha antibodies and another drug |
| 06/10/2004 | WO2004003235A3 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 06/10/2004 | WO2004003145A3 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 06/10/2004 | WO2004000225A3 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 06/10/2004 | WO2003102140A3 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 06/10/2004 | WO2003101950A3 Methods for enhancing motor performance and/or endurance |
| 06/10/2004 | WO2003087307A3 Use of interleukin-19 to treat cervical cancer |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003080037A3 Use of ltb4 antagonists in veterinary medicine |
| 06/10/2004 | WO2003077841A9 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases |
| 06/10/2004 | WO2003070191A8 Tamper-resistant transdermal opioid delivery devices |
| 06/10/2004 | WO2003066842A3 Method for producing recombinant proteins in micro-organisms |
| 06/10/2004 | WO2003048116A3 Esters and amides as ppar-alpha agonists ____________ |
| 06/10/2004 | WO2003037258A3 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 06/10/2004 | WO2003035049A3 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections |
| 06/10/2004 | WO2003013603A8 Modulators of p-selectin glycoprotein ligand 1 |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | WO2002090600A3 A method for regulating immune function in primates using the foxp3 protein |
| 06/10/2004 | WO2002040629A3 Promoters exhibiting endothelial cell specificity and methods of using same |
| 06/10/2004 | WO2002038168A3 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 06/10/2004 | US20040110928 Peptide conjugates for drug delivery |
| 06/10/2004 | US20040110846 Perylenequinones for use with immunotherapy agents |
| 06/10/2004 | US20040110843 in a patient suffering from a co-morbid condition comprising placing in the fossa navicularis a semi-solid composition comprising a vasoactive prostaglandin and a penetration enhancer; co-morbid condition is diabetes mellitus, hypertension, etc |
| 06/10/2004 | US20040110839 Compounds and compositions for delivering active agents |
| 06/10/2004 | US20040110838 side effect reduction of anticarcinogenic agents, by administering irinotecan and/or taxol, with group VI compounds such as seleno-L-methionine |
| 06/10/2004 | US20040110831 Urokinase inhibitors |
| 06/10/2004 | US20040110825 Method for treating sepsis |
| 06/10/2004 | US20040110799 Use of a PPAR-alpha agonist to treat patients suffering from weight gain associated with a PPAR-gamma agonist treatment |
| 06/10/2004 | US20040110792 Methods for assessing and treating leukemia |
| 06/10/2004 | US20040110785 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 06/10/2004 | US20040110783 Drug mixture comprising acetylcholinesterase inhibitor huperzine A, and secretagogue glycine and L-glutamine; stimulants |
| 06/10/2004 | US20040110781 Pharmaceutical compositions containing indistinguishable drug components |
| 06/10/2004 | US20040110776 Associated with glaucoma or ocular hypertension; propentofylline was unexpectedly discovered to stimulate the expression of metalloproteinase-3 (MMP-3; stromelysin) in cultured human trabecular meshwork cells |
| 06/10/2004 | US20040110774 HIV infection, AIDS, and adenosine deaminase deficiency-dependent severe immunodeficiency disease (ADA SCID); antagonists are antibodies |
| 06/10/2004 | US20040110769 Antitumor agents for cancer treatment; 5-(3-chlorophenyl)-alpha-(4-chlorophenyl)-alpha-(1-methyl-1H-imidazol-5-yl)tetrazolo[1,5-a]quinazoline-7-methanamine with tamoxifen for example |
| 06/10/2004 | US20040110752 2-amino-5-((hetero)aryl)-thiazole derivatives; treatment of disorders such as cancer, immunologic disorders and allergic disorders, optionally in combination with other drugs such as immunosuppressants |
| 06/10/2004 | US20040110747 Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions |
| 06/10/2004 | US20040110744 1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 06/10/2004 | US20040110738 Administering silver- or metal compound as microbiocidal, anti-biofilm, bactericidal, antiinflammatory, fungicidal, viricidal and/or anticarcinogenic agent; skin disorders, dentistry |
| 06/10/2004 | US20040110735 Methods of activating receptor using amphiphilic drug-oligomer conjugates |
| 06/10/2004 | US20040110734 Combinations for the treatment of inflammatory disorders |
| 06/10/2004 | US20040110727 Administering inhibitor of aldehyde detoxifying agent, such as buthionine sulphoximine or crotonaldehyde to treat cancer; hydrolysis by esterase |
| 06/10/2004 | US20040110723 Modified psma ligands and uses related thereto |
| 06/10/2004 | US20040110719 Therapeutic use of methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| 06/10/2004 | US20040110712 Methods for treating patients and identifying therapeutics |
| 06/10/2004 | US20040110707 Method of treating neurological diseases |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110693 Agent for treating diabetes mellitus |
| 06/10/2004 | US20040110690 Transporter peptide capable of translocating across biological membrane of pancreatic B-cells, hepatocytes, colon cells, muscle cells and/or lung cells; drug delivery; biochemical conjugation |
| 06/10/2004 | US20040110687 Administering immunomodulatory peptides for side effect reduction from cancer chemotherapy or radiotherapy; diarrhea, mucositis, stomatitis and proctitis |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110668 Nucleic acid sequences differentially expressed in cancer tissue |
| 06/10/2004 | US20040110662 Administering cytotoxic agent and heat shock protein 90 inhibitors such as ansamycins for synergistic growth inhibitors of cells. This therapy as cytotoxic agent and as cell growth inhibitors |
| 06/10/2004 | US20040110661 Rapidly disintegrating tablet comprising an acid-labile active ingredient |
| 06/10/2004 | US20040110250 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 06/10/2004 | US20040110237 Protein localization assays for toxicity and antidotes thereto |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040110168 Diagnostics and therapeutics for osteoporosis |
| 06/10/2004 | US20040109901 Compositions and methods for nutrition supplementation |
| 06/10/2004 | US20040109886 Reducing drug abuse of narcotics using drug delivery system |
| 06/10/2004 | US20040109878 Removal cancer, organ transplant and autoimmune cells from bone marrow, blood |
| 06/10/2004 | US20040109877 Rna viruses; attenuation influenza virus |